13 November 2019

Toxicology in Vitro

Toxicology in Vitro publishes original research papers and reviews on the application and use of in vitro systems for assessing or predicting the toxic effects of chemicals and elucidating their mechanisms of action. These in vitro techniques include utilizing cell or tissue cultures, isolated cells, tissue slices, subcellular fractions, transgenic cell cultures, and cells from transgenic organisms, as well as in silico modelling. The Journal focuses on investigations that involve the development and validation of new in vitro methods, e.g. for prediction of toxic effects based on traditional and in silico modelling; on the use of methods in high-throughput toxicology and pharmacology; elucidation of mechanisms of toxic action; the application of genomics, transcriptomics and proteomics in toxicology, as well as on comparative studies that characterize the relationship between in vitro and in vivo findings.
The Journal strongly encourages the submission of manuscripts that focus on the development of in vitro methods, their practical applications and regulatory use (e.g. in the areas of food components cosmetics, pharmaceuticals, pesticides, and industrial chemicals).

The Latest News from TIV (RSS feed):

RSS Error: A feed could not be found at `https://www.journals.elsevier.com/toxicology-in-vitro/rss`; the status code is `403` and content-type is `text/html; charset=UTF-8`

                               

                               

                               

                               

                               

Related content

Celebrating Talents in Toxicology: ESTIV Awards at ASCCT 2024

We are thrilled to announce the recipients of the ESTIV Awards recognizing outstanding early-career scientists at last week’s ASCCT Congress

ASCCT-ESTIV Award Winners Series: Dr. Eliska Kuchovska & Tiago Marques Pedro

  • News

Registration is open for the next joint ASCCT-ESTIV webinar featuring two excellent early career scientists and award recipients

Welcoming Luiz Ladeira to the ESTIV Board!

  • News

We are excited to announce that Dr. Luiz Ladeira has joined the ESTIV Board! Luiz brings exceptional expertise in physiological maps and AOP research, and a strong commitment to advancing in vitro and in silico toxicology.

Silver Sponsor

Memorandum of Understanding